Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Anti-phospholipid antibodies in SLE can cause thrombosis and bone necrosis.

Teenage girls with Lupus often struggle with the disease's impact on their looks, which may lead them to change their medication without a doctor's advice.

Pericardiocentesis and immunosuppressants effectively treat cardiac tamponade in pregnant women with SLE.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

The combination of minoxidil and cyclosporine improved hair growth in short anagen syndrome.

Testosterone makes XX skin more like male skin by changing its structure and cell makeup.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

A boy's hair, nails, and skin improved after 6 months of steroid treatment.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Oral propranolol successfully treated a baby's skin growth and ulceration linked to PELVIS syndrome.

Personalized acne treatments and new therapies show promise for better results.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

New treatments for Alopecia Areata, like JAK inhibitors, are effective, and future research is exploring advanced therapies.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Emerging injectable treatments like PRP, stem cells, and exosomes show promise for safer, more effective hair growth.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Future acne treatments should aggressively target inflammation to prevent scarring.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.